| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/22/2004 | US20040076631 Treating infections caused by respiratory syncytial virus, transfected eukaryotic cells, isolating human B cells from transfected mouse, use for immunoassay, diagnosis the virus, test kits |
| 04/22/2004 | US20040076629 Polypeptide with 46 kDalton HMFG differentiation antigen binding specificity and clotting factors V and VIII light-chain homologies, fusion protein, polynucleotide and polyribonucleotide encoding the polypeptide, anti-polypeptide antibodies, kits and methods of use thereof |
| 04/22/2004 | US20040076628 Use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/22/2004 | US20040076627 Humanised antibodies |
| 04/22/2004 | US20040076626 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 04/22/2004 | US20040076625 A fusion proteins comprising self or non-self antigens, is used for treatment and prevention of immunoglobulin E related diseases, gene expression |
| 04/22/2004 | US20040076613 Vector system |
| 04/22/2004 | US20040076611 Molecular antigen arrays |
| 04/22/2004 | US20040076608 Cytokine uses; compositions; methods |
| 04/22/2004 | US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/22/2004 | US20040076604 Tolergenic antigen presenting cells and in treating immune-inflammatory conditions |
| 04/22/2004 | US20040076589 Comprises albuterol/insulin; eliminates need for injections |
| 04/22/2004 | CA2823937A1 Hiv vaccine formulations |
| 04/22/2004 | CA2820949A1 Novel immunogenic proteins of leptospira |
| 04/22/2004 | CA2501947A1 Azaindole derivatives as inhibitors of p38 kinase |
| 04/22/2004 | CA2501945A1 Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
| 04/22/2004 | CA2501941A1 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 04/22/2004 | CA2501939A1 Novel immunogenic proteins of leptospira |
| 04/22/2004 | CA2501626A1 Methods for treating post-surgical pain by administering a nerve growth factor antagonist and compositions containing the same |
| 04/22/2004 | CA2501616A1 Antibody therapy |
| 04/22/2004 | CA2501476A1 Hiv vaccine formulations |
| 04/22/2004 | CA2501289A1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 04/22/2004 | CA2499081A1 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 04/22/2004 | CA2498768A1 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics |
| 04/22/2004 | CA2497798A1 Production of peptides in plants as viral coat protein fusions |
| 04/22/2004 | CA2494104A1 Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders |
| 04/21/2004 | WO2004035768A1 Antigen transduced t cells used as a delivery system for antigens |
| 04/21/2004 | EP1411124A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/21/2004 | EP1411118A1 CELL PROLIFERATION INHIBITORS CONTAINING ANTI−GLYPICAN 3 ANTIBODY |
| 04/21/2004 | EP1411064A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 04/21/2004 | EP1411061A1 Poly-alpha2,8-sialic acid mimetic peptides and their application |
| 04/21/2004 | EP1410820A2 Nasal delivery devices |
| 04/21/2004 | EP1410807A1 Methods and compositions useful for inhibition of angiogenesis |
| 04/21/2004 | EP1410805A1 Vaccine against HPV |
| 04/21/2004 | EP1410804A1 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 04/21/2004 | EP1410040A2 Method for identifying substances which modulate interleukin 4 (il-4) signaling |
| 04/21/2004 | EP1410035A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 04/21/2004 | EP1410022A2 Detection and treatment of prostate cancer |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1409748A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 04/21/2004 | EP1409740A2 Asthma-associated gene |
| 04/21/2004 | EP1409734A2 Diagnosis and treatment of cancer |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | EP1409694A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 04/21/2004 | EP1409692A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 04/21/2004 | EP1409690A2 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
| 04/21/2004 | EP1409684A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 04/21/2004 | EP1409683A2 i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF |
| 04/21/2004 | EP1409682A2 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 04/21/2004 | EP1409680A2 Novel human proton-gated channels |
| 04/21/2004 | EP1409675A1 Gene involved in apoptosis regulation |
| 04/21/2004 | EP1409673A2 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 04/21/2004 | EP1409665A2 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production |
| 04/21/2004 | EP1409658A2 Aggrecanase molecules |
| 04/21/2004 | EP1409654A1 Immunological control of beta-amyloid levels in vivo |
| 04/21/2004 | EP1409648A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions |
| 04/21/2004 | EP1409645A1 Probiotic lactobacillus salivarius strains |
| 04/21/2004 | EP1409549A2 Compositions and methods for the diagnosis and treatment of tumor |
| 04/21/2004 | EP1409547A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 04/21/2004 | EP1409546A2 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 04/21/2004 | EP1409544A2 Human dr4 antibodies and uses thereof |
| 04/21/2004 | EP1409542A2 Blood group antigen fusion polypeptides and methods of use thereof |
| 04/21/2004 | EP1409533A2 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine |
| 04/21/2004 | EP1409528A2 Novel compounds |
| 04/21/2004 | EP1409527A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 04/21/2004 | EP1409523A2 Pancam nucleic acids and polypeptides |
| 04/21/2004 | EP1409506A1 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
| 04/21/2004 | EP1409077A2 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 04/21/2004 | EP1409018A2 Stable lyophilized pharmaceutical formulation of igg antibodies |
| 04/21/2004 | EP1409017A2 Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications |
| 04/21/2004 | EP1409016A2 Antibodies to opgl |
| 04/21/2004 | EP1409015A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 04/21/2004 | EP1409014A1 Immunogenic compositions comprising an antigen and a purified m protein from respiratory syncytial virus |
| 04/21/2004 | EP1409013A1 Vaccines comprising aluminium adjuvants and histidine |
| 04/21/2004 | EP1409012A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 04/21/2004 | EP1409011A1 Prime-boost vaccination strategy |
| 04/21/2004 | EP1409009A1 Therapeutical vaccination |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1408951A2 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 04/21/2004 | EP1408941A2 Pharmaceutical composition and method of using the same |
| 04/21/2004 | EP1408908A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 04/21/2004 | EP1408811A2 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 04/21/2004 | EP1053301B1 A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use |
| 04/21/2004 | EP0857068B1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 04/21/2004 | CN1491281A Neurotonin and use thereof |
| 04/21/2004 | CN1491116A Hepatitis B virus treatment |
| 04/21/2004 | CN1491115A Use of botulinum toxin for treatment of articular pathologies |
| 04/21/2004 | CN1490409A Preparing method for recombinant chBJSTWO protein and use thereof |
| 04/21/2004 | CN1490335A Method and application of expressions of sTNFR immuno desmolin fusion protein and polypeptide |
| 04/21/2004 | CN1490056A Immune method and composition for HIV-1 |
| 04/21/2004 | CN1490053A Selection and production of inactivated vaccine Lu8 line of hepatitis A |
| 04/21/2004 | CN1490052A Recombined fowl pox living carrier vaccine for co-expression of MIV-1CNB and hlL-6 proteins |
| 04/21/2004 | CN1490051A Recombined fowl pox living carrier vaccine for expression of FMDV protein |
| 04/21/2004 | CN1146664C Fusion polypeptides comprising and IgE-binding domain and HSA component, and their diagnostic and therapeutic uses |
| 04/21/2004 | CN1146445C Materials and methods relating to diagnosis and treatment of pre-eclampsia and diabetes |
| 04/21/2004 | CN1146444C Vaccine composition comprising polysaccharide conjugate antigen and adsorbed onto aluminium phosphate |
| 04/21/2004 | CN1146443C Use of Newcastle virus in preparation of vaccin for intra-ovular immuno-inoculation |
| 04/21/2004 | CN1146442C Lympha toxin-alpha/beta compositions as anti tumor agent and antilympha toxin beta receptor antibody |
| 04/21/2004 | CN1146441C Composition of containing lympha toxin beta receptor |
| 04/21/2004 | CN1146440C Vascular endothelial growth factor-B |